Your browser (Internet Explorer 7 or lower) is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.

If you are using IE 9 already, make sure you turn off "Compatibility View".


Version française
To be translated / À traduire [?]


AVA is requesting your assistance.  We thank you for your commitment to the specialty of vascular access. There is a need to continue to advance best practice, stand as a united voice, and participate in advocacy for the most important stakeholder in this discussion—the patient. To this end, and as a beginning, we are asking for your highly valued opinion and comments regarding 17 topics that may eventually be researched, supported by the graded evidence, and collaboratively written to stand as position papers from AVA.

Click here to begin the survey.

Please review the following statements and then proceed to the survey to give us your opinion and comments regarding appropriateness and priority.

1. All Central Venous Access Devices (CVAD) will be placed with ultrasound guidance.
2. An intraosseous (IO) device is first-line treatment in emergent situations when venous access cannot be immediately established.
3. A PIV is inserted in a sterile manner and requires the same care and maintenance as a CVAD.
4. Every patient requiring a vascular access device (VAD) will be assessed and referred to the most qualified clinician for highest probability of first attempt access.
5. Patient's requiring vascular access are assessed using a comprehensive site-specific VAD algorithm.
6. All patients (in an acute or skilled healthcare facility) with a CVAD are assessed daily by a healthcare professional with the requisite validated knowledge, skills and training regardless of discipline.
7. All CVAD insertions will have an officially designated empowered observer to stop the procedure if a concern or break of sterile technique is identified (second set of qualified eyes). The observer also serves as the official recorder of the procedure. Acceptable CVAD tip location in the adult population is from distal SVC to right atrium for insertions in upper body approach.
8. No CVAD insertion will have more lumens than is clinically justified.
9. A catheter will occupy no greater than 1/3 of the vessel in its natural state (33% catheter/vessel ratio)*In high risk populations consider more conservative ratio.
10. The use of advanced tip-location technology on insertion of a CVAD is preferred over traditional chest x-ray verification (excluding those placed fluoroscopically).
11. A clinician who removes a CVAD must have annual documented competency.
12. For all high-risk patients and for catheters with an expected dwell of greater than six days, use a catheter with protective properties (antifungal/antithrombogenic/antimicrobial) unless contraindicated.
13. All vascular access devices (centrally or peripherally inserted) will be placed by the most qualified clinician with the requisite knowledge, skills, and training regardless of discipline.
14. An arterial catheter is inserted in a sterile manner and requires the same care and maintenance as a CVAD.
15. Use a sutureless securement device for intravascular catheters to reduce the risk of needlestick injury, infection, motion, and migration.
16. Modified Seldinger technique (MST) will be used for insertion of all central venous access devices (i.e. micropuncture).

Have an opinion and a passion for what you have just read?  Add your voice and be heard! 

Click here to begin the survey.

AVA: Striving to be your source and your voice for Vascular Access.

Judy Thompson, AVA President
Andrea Owens, AVA President-Elect

Posted in: Current News
Actions: E-mail | Permalink |


We're pleased to let you know that CVAA is participating in an online knowledge sharing network called Sosido ( Sosido was created for and by healthcare associations, to speed knowledge transfer, promote collaboration, highlight the important work and research by members, and bridge silos by publicizing the contributions of each specialty group to the broader healthcare community. CVAA joins a growing network of associations and research groups on Sosido, including the Canadian Association of Nurses in Oncology (CANO).

CVAA members will receive:

  • - A weekly email digest summarizing all activity in the CVAA community. You don’t have to log in to participate, and anything that’s important will come to your inbox, including:

  • - Updates on all publications authored by CVAA members that week. Sosido automatically delivers a current and complete snapshot of the work of our CVAA community.

  • - A summary of new articles released that week from journals chosen by you.

  • - Access to a secure CVAA members-only forum to ask and answer questions.

(Watch a slide tour of Sosido.)

Please note that you can unsubscribe from emails or remove yourself from the network at any time.

We look forward to staying in touch with you through the CVAA community on Sosido, and we welcome your questions and feedback.



If you are interested, consider getting involved in this worldwide study on the use and management of peripheral catheters.

More information here and here.



CVAA is now on Twitter!!


If you are too, follow us to keep up to date with the latest and greatest, at 140 characters at a time